EPFL scientists have carried out a genomic and evolutionary study of a large and
März 2017 The proteins that domesticated our genomes EPFL scientists have carried
In a world first, EPFL scientists have synthesized and studied modified forms of
In a world first, EPFL scientists have synthesized and studied modified forms of
Researchers at EPFL, UNIL and CHUV have developed a new way to “switch off” the therapy
Researchers at EPFL, UNIL and CHUV have developed a new way to “switch off” the therapy
Researchers from EPFL have developed a novel series of systems genetics tools to
tool begins new era for biology and personalized medicine Researchers from EPFL have
Researchers at Eawag, the ETH and the EPFL have now developed a computer model that
Researchers at Eawag, the ETH and the EPFL have now developed a computer model that
Initiative (CZI) and DAF, an advised fund of Silicon Valley Community Foundation, have
Initiative (CZI) and DAF, an advised fund of Silicon Valley Community Foundation, have
For years, attempts have been made to understand the mechanism behind the proliferation
Putting cells „on a diet“ for new therapies against cancer For years, attempts have
Scientists are exploring the proteins’ potential as a way to control CRISPR and reduce off-target effects.
But CRISPR faces safety concerns because scientists have only limited ways to control
Three studies showing large DNA deletions and reshuffling heighten safety concerns about heritable genome editing.
experiments that use the gene-editing tool CRISPR–Cas9 to modify human embryos have
Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), a gene-editing tool, is a promising way to treat diseases by removing, adding, or altering sections of deoxyribonucleic acid (DNA) sequences. It is currently the most straightforward, most flexible, and accurate method of gene manipulation.
Previous studies have shown the tool as a potential treatment method for viral diseases
